Michael J. Oxendine-Burns

Michael J. Oxendine-Burns

Auto-generated profile, based on publicly available information

Michael J. Oxendine-Burns

Center for Vascular and Developmental Biology, Feinberg Cardiovascular and Renal Research Institute, Northwestern University, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2020 in Nature
Verified
Journal Article
Closed access
PDF file
XLXiaolei Liu
Xiaolei Liu
ECEster De la Cruz
Ester De la Cruz
XGXiaowu Gu
Xiaowu Gu
LBLászló Bálint
László Bálint
MOMichael Oxendine-Burns
Michael Oxendine-Burns
GOGuillermo Oliver
Guillermo Oliver

30 April 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
WMWanshu Ma
Wanshu Ma
HGHyea Jin Gil
Hyea Jin Gil
XLXiaolei Liu
Xiaolei Liu
LDLauren P. Diebold
Lauren P. Diebold
MMMarc A. Morgan
Marc A. Morgan
GOGuillermo Oliver
Guillermo Oliver
Recent findings indicate that mitochondrial respiration regulates blood endothelial cell proliferation; however, its role in differentiating lymphatic endothelial cells (LECs) is unknown. We hypothesized that mitochondria could work as a sensor of LECs’ metabolic specific needs by determining their functional requirements according to their differentiation status and local tissue microenvironment. Accordingly, we conditionally deleted the QPC subunit of mitochondrial complex III in differentiating LECs of mouse embryos. Unexpectedly, mutant mice were devoid of a lymphatic vasculature by mid-gestation, a consequence of the specific down-regulation of main LEC fate regulators, particularly Vegfr3, leading to the loss of LEC fate. Mechanistically, this is a result of reduced H3K4me3 and H3K27ac in the genomic locus of key LEC fate controllers (e.g., Vegfr3 and Prox1). Our findings indicate that by sensing the LEC differentiation status and microenvironmental metabolic conditions, mitochondrial complex III regulates the critical Prox1-Vegfr3 feedback loop and, therefore, LEC fate specification and maintenance.